Simron Singh

7.6k citations
176 papers · 3.7k indexed · 2 hit papers · h-index 33

Impact in

  • Neurology top 0.5%
    • Neuroblastoma Research and Treatments
  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer survivorship and care

Papers in

    • Lung Cancer Research Studies 97
    • COVID-19 and healthcare impacts 12
    • Cancer survivorship and care 12
    • Global Cancer Incidence and Screening 9
    • Neuroblastoma Research and Treatments 72

Simron Singh

165 papers receiving 3.7k citations

Hit Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study 2024 · 113 citations
1132014202620182022100200300400500

Peers

Simron Singh
Comparison fields: 5 of 111
  • Neurology 1.7k
  • Oncology 2.8k
  • Epidemiology 2.5k
  • Otorhinolaryngology 220
  • Gastroenterology 123
Replace Eva Segelov with:
Eva Segelov Australia
Giovanni Rosti Italy
Hassan Errihani Morocco
Mary Dillhoff United States
Susan C. Pitt United States
Daneng Li United States
Eliza W. Beal United States
E. Aileen Clarke Canada
Libby Ellis United Kingdom
Maureen P. Neary United States
Simron Singh relative to Eva Segelov Australia Eva Segelov's profile →
Citations per field
00.5×
Eva Segelov · 1×
Citations per year

Countries citing papers authored by Simron Singh

Since Specialization
Citations

This map shows the geographic impact of Simron Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simron Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simron Singh more than expected).

Fields of papers citing papers by Simron Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simron Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simron Singh. The network helps show where Simron Singh may publish in the future.

Co-authors

The 25 scholars most cited alongside Simron Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simron Singh Line = papers co-authored together Simron Singh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20242
3 20240
4 20244
5 20233
6 20237
7 20231
8 202111
9 20204
10 202011
11 20192
12 201811
13 20171
14 2017262
15
ASSOCIATION OF DISEASE PROGRESSION, HEALTH-RELATED QUALITY OF LIFE, AND UTILITY IN PATIENTS WITH ADVANCED, NONFUNCTIONAL, WELL-DIFFERENTIATED GASTROINTESTINAL OR LUNG NEUROENDOCRINE TUMORS IN THE PHASE 3 RADIANT-4 TRIAL
20160
16 20162
17
A systematic review of surgery for non-curative gastric cancer (Systematic Reviews : Current issues in gastric cancer)
20122
18 201238
19 201055
20 201053

About Simron Singh

Simron Singh is a scholar working on Oncology, Neurology, Epidemiology, Otorhinolaryngology and Health Informatics, having authored 176 papers that have together received 3.7k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (104 papers), Lung Cancer Research Studies (97 papers), Neuroblastoma Research and Treatments (72 papers), Economic and Financial Impacts of Cancer (13 papers), COVID-19 and healthcare impacts (12 papers), Cancer survivorship and care (12 papers), Global Cancer Incidence and Screening (9 papers) and Palliative Care and End-of-Life Issues (9 papers). The work is most often cited by research in Neurology (1.7k citations), Oncology (2.8k citations), Epidemiology (2.5k citations), Otorhinolaryngology (220 citations) and Gastroenterology (123 citations). Simron Singh has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Calvin Law, Julie Hallet, Ning Liu, Refik Saskin, Moisés Cukier, David Chan, Jonathan Strosberg, Eva Segelov, Matthew C. Cheung and Corwyn Rowsell. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Neuroendocrinology, Endocrine Related Cancer and Pancreas.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026